Cesar Ramos Remus

Cesar Ramos Remus

Universidad de Guadalajara - Guadalajara / Mexico
Medical and Health Sciences / Rheumatology
AD Scientific Index ID: 4313526
University of Guadalajara
person_outline Cesar Ramos Remus's MOST POPULAR ARTICLES
1-) Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trialJS Smolen, A Beaulieu, A Rubbert-Roth, C Ramos-Remus, J Rovensky, ...The Lancet 371 (9617), 987-997, 200816662008
2-) Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research …K Visser, W Katchamart, E Loza, JA Martinez-Lopez, C Salliot, J Trudeau, ...Annals of the Rheumatic Diseases 68 (7), 1086-1093, 20096122009
3-) Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trialD Khanna, CJF Lin, DE Furst, J Goldin, G Kim, M Kuwana, Y Allanore, ...The Lancet Respiratory Medicine 8 (10), 963-974, 20204012020
4-) Baricitinib, methotrexate, or combination in patients with rheumatoid arthritis and no or limited prior disease‐modifying antirheumatic drug treatmentR Fleischmann, M Schiff, D van der Heijde, C Ramos‐Remus, A Spindler, ...Arthritis & Rheumatology 69 (3), 506-517, 20174442017
5-) Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological …D van der Heijde, JCC Wei, M Dougados, P Mease, A Deodhar, ...The Lancet 392 (10163), 2441-2451, 20183822018